EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 157 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $200,000 | -47.2% | 7,577 | -11.1% | 0.00% | -100.0% |
| Q2 2022 | $379,000 | -10.2% | 8,527 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $422,000 | -2.8% | 8,527 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $434,000 | -54.0% | 8,527 | -49.6% | 0.00% | -50.0% |
| Q3 2021 | $944,000 | +30.4% | 16,917 | 0.0% | 0.00% | +100.0% |
| Q2 2021 | $724,000 | +26.4% | 16,917 | +23.3% | 0.00% | 0.0% |
| Q1 2021 | $573,000 | +0.7% | 13,717 | +12.3% | 0.00% | 0.0% |
| Q4 2020 | $569,000 | +9.6% | 12,217 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $519,000 | -11.4% | 12,217 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $586,000 | +4.3% | 12,217 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $562,000 | -20.8% | 12,217 | +3.4% | 0.00% | 0.0% |
| Q4 2019 | $710,000 | – | 11,817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |